Medication info
Tenegliptin MR Tablet 10/750 mg

Tenegliptin MR Tablet 10/750 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›750mg / 1 tablet
Manufacturer / importer
Korea Pavis Pharmaceutical Co., Ltd.
Appearance
Yellow egg-shaped extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201430 · Approved 2022.04.04 · Insurance code 621804450

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored, and the dose should be adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering medicines. Since this may cause changes in blood glucose control, any change in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole without splitting, crushing, grinding, or chewing it.

Ingredients

Manufacturer
Korea Pavis Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used together with diet and exercise to help blood sugar control in patients with type 2 diabetes. In particular, administering teneligliptin and metformin together helps to effectively control blood sugar levels. It is used to stabilize blood sugar levels and maintain a healthy lifestyle through continuous treatment and management.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored, and the dose should be adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering medicines. Since this may cause changes in blood glucose control, any change in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole without splitting, crushing, grinding, or chewing it.

Precautions

This medication is used to treat diabetes. Care must be taken as rare side effects, such as severe lactic acidosis, may occur when taking this medication. Lactic acidosis is a serious condition caused by the accumulation of lactic acid in the body and can sometimes be life-threatening. Moreover, if taken together with insulin or sulfonylurea medications, severe hypoglycemia may occur, so blood sugar levels should be closely monitored. Patients with moderate to severe renal impairment, heart failure, acute myocardial infarction, sepsis, or liver dysfunction should not use this medication, as it may pose risks. Before tests involving iodine contrast agents, this medication should be stopped at least 48 hours in advance, and it should only be resumed after confirming that kidney function is normal following the test. Women who are pregnant or may become pregnant, as well as patients with severe infections or traumatic injuries, should also avoid taking this medication. Since this medication poses a risk of hypoglycemia, special caution is needed when there are irregular meals, intense exercise, or if used in combination with other diabetes medications. Some patients may experience side effects such as abdominal pain, constipation, liver dysfunction, pneumonia, skin rashes, acute pancreatitis; if any unusual symptoms occur, consult a physician immediately. During treatment, it is important to regularly monitor kidney function, blood tests, and vitamin B12 levels. Alcohol intake may increase the risk of lactic acidosis, so it is advisable to avoid excessive drinking. Elderly patients may have decreased kidney function, so dosage adjustments and regular check-ups are necessary. During the course of taking this medication, it is crucial to be fully aware of the symptoms of hypoglycemia and how to handle them, and to take caution when driving or performing hazardous tasks. In case of an overdose, seek immediate medical attention for appropriate treatment, and blood dialysis may be required. This medication has not established safety for use in children, so it is best not to use it. Finally, keep this medication out of reach of children and do not transfer it to another container for safety.

Side effects

Severe lactic acidosis, severe hypoglycemia, hypoglycemia, constipation, intestinal obstruction, liver dysfunction, interstitial pneumonia, bullous pemphigoid, acute pancreatitis, dizziness, abdominal distension, abdominal discomfort, nausea, abdominal pain, bloating, stomatitis, gastric polyp, colon polyp, duodenal ulcer, gastroesophageal reflux disease, diarrhea, loss of appetite, elevated amylase, elevated lipase, increased AST (GOT), increased ALT (GPT), elevated GGT, increased ALP, proteinuria, ketonuria, potential hematuria, eczema, rash, itching, allergic dermatitis, arthralgia, increased CK (CPK), elevated serum potassium concentration, fatigue, allergic rhinitis, elevated serum uric acid, peripheral edema, shingles, limb pain, upper abdominal pain, gastritis, headache, upper respiratory infection, tremors, weakness, hunger, fatigue, facial edema, dyspepsia, nausea, viral upper respiratory infection, rhinitis, cold sweat, diabetic retinopathy, visual impairment, cough, pulmonary congestion, dyspnea, drug overdose, benign prostatic hyperplasia, headache, cerebral infarction, hyperglycemia, liver biopsy, neutropenia, abnormal blood sugar, increased blood sugar, increased blood pressure, hepatic coma, lumbar spinal canal stenosis, spinal disc protrusion, spinal disc disorder, spinal ligament ossification, spinal foraminal stenosis, rotator cuff syndrome, bladder mass, ureteral stone disease, urinary stones, coronary artery disease, unstable angina, gastroesophageal reflux disease, gastric polyps, gastritis, bile duct obstruction, chronic cholecystitis, soft tissue inflammation, pneumonia, cataract, depression, iliac artery stenosis, dizziness, benign prostatic hyperplasia, knee surgery, dizziness, diabetic neuropathy, sensory abnormalities, muscle weakness, back pain, limb pain, tendonitis, neck pain, bone pain, osteoarthritis, osteoporosis, muscle cramps, foot deformity, hypertrophic osteoarthritis, bursitis, spinal arthritis, postmenopausal osteoporosis, chronic gastritis, irritable bowel syndrome, vomiting, abdominal pain, gastrointestinal motility disorder, decreased gastrointestinal motility, enteritis, toothache, anorectal discomfort, acquired mixed hyperlipidemia, hypertriglyceridemia, vitamin D deficiency, abnormal weight gain, essential hypertension, orthostatic hypotension, white coat hypertension, bleeding, cough, insomnia, urticaria, otalgia, iron deficiency anemia, food allergy, pressure sore ulcer, glaucoma, blurred vision, age-related macular degeneration, hyperthyroidism, hyperparathyroidism, angina, otalgia, hearing loss, endolymphatic hydrops, increased blood creatinine, increased blood urea, anemia, benign, malignant, and unspecified neoplasms (including cysts and polyps), foot fracture, uterine abscess, gastroenteritis, influenza, subcutaneous abscess, musculoskeletal chest pain, spinal disc degeneration, falls, animal bites, radial fracture, ovarian cyst, vulvar pruritus, menopausal symptoms, toxic hepatitis, non-alcoholic fatty liver disease, alcoholic liver disease, eyelid injury, ligament sprain, lip injury, contusion

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air from entering, and it is advisable to keep it at room temperature between 1 and 30 degrees Celsius. This helps maintain the efficacy of the medication and prevents deterioration.

Appearance and packaging

Appearance

Yellow egg-shaped extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.